Issue 11, 2025, Issue in Progress

Harnessing in vitro cytotoxicity and antibacterial potential of a novel silver-DABCO framework against multi-drug-resistant pathogens

Abstract

This study aimed to synthesize and characterize silver-based metal–organic frameworks (Ag-MOFs) using 1,4-diazabicyclo[2.2.2]octane (DABCO) as the organic ligand and to assess their antibacterial and cytotoxic properties. The formation of Ag-MOF-D was confirmed by the appearance of a brown solution and a surface plasmon resonance peak at 394 nm in UV-vis spectroscopy. Fourier-transform infrared spectra showed characteristic peaks at 673, 705, 883, 1060, 1382, 1654, and 3250 cm−1. Powder X-ray diffraction patterns indicated a crystalline structure with peaks at 33°, 38°, 55°, and 66°, with an average particle size of 15.68 nm. Ag-MOF-D displayed thermal stability up to 650 °C with a residual mass of 91.50%. Scanning electron microscopy revealed spherical morphology with minimal aggregation, while energy-dispersive X-ray spectroscopy showed 88.64 wt% Ag+. Transmission electron microscopy indicated mono-dispersed spherical particles with an average diameter of 10.47 ± 1.80 nm and a lattice fringe spacing of 0.19 nm. The type II isotherm and Brunauer–Emmett–Teller analysis suggested a mesoporous structure of Ag-MOF-D with a surface area of 5.3005 m2 g−1 and an average pore diameter of 9.46 nm. Minimum inhibitory and minimum bactericidal concentration values against multi-drug-resistant bacterial strains ranged from 3.90 to 7.80 μM and 7.8 to 62.5 μM, respectively. In vitro cytotoxicity testing on Vero cell lines indicated a dose-dependent decrease in cell viability, with an IC50 value of 1.701 × 10−2 mg mL−1. These findings suggest that Ag-MOF-D holds potential for antibacterial applications and biocompatibility, with future opportunities for environmental and food safety applications.

Graphical abstract: Harnessing in vitro cytotoxicity and antibacterial potential of a novel silver-DABCO framework against multi-drug-resistant pathogens

Supplementary files

Transparent peer review

To support increased transparency, we offer authors the option to publish the peer review history alongside their article.

View this article’s peer review history

Article information

Article type
Paper
Submitted
21 Jan 2025
Accepted
07 Mar 2025
First published
17 Mar 2025
This article is Open Access
Creative Commons BY license

RSC Adv., 2025,15, 8180-8188

Harnessing in vitro cytotoxicity and antibacterial potential of a novel silver-DABCO framework against multi-drug-resistant pathogens

S. S. Desai, K. A. Deepika Roy, P. Abishad, R. Krishnan, V. K. Vinod, A. Karthikeyan, P. B. Aswathi, S. Juliet, S. B. Barbuddhe, D. B. Rawool and J. Vergis, RSC Adv., 2025, 15, 8180 DOI: 10.1039/D5RA00509D

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements